[Federal Register Volume 85, Number 221 (Monday, November 16, 2020)]
[Notices]
[Pages 73054-73056]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25194]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 85 FR 30106-30708, dated May 20, 2020) is 
amended to reflect the reorganization of the Division of Sexually 
Transmitted Disease Prevention within the National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control 
and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the titles and mission and function 
statements for the Division of Sexually Transmitted Disease Prevention 
(CVJD) and insert the following:

[[Page 73055]]

    Division of Sexually Transmitted Disease Prevention (CVJD). (1) In 
cooperation with other CDC components, administers operational programs 
for the prevention of sexually transmitted diseases (STD); (2) provides 
consultation, training, statistical, educational, epidemiological, and 
other technical services to assist state and local health departments 
in the planning, development, implementation, evaluation, and overall 
improvement of STD prevention programs; (3) supports a nationwide 
framework for effective surveillance of STD other than HIV; (4) 
conducts behavioral, clinical, epidemiological, preventive health 
services, and operational research into factors affecting the 
prevention and control of STD; (5) provides leadership and coordinates, 
in collaboration with other CDC components, research and program 
activities that focus on STD and HIV prevention; (6) promotes linkages 
between health department STD programs and other governmental and non-
governmental partners who are vital to effective STD prevention 
efforts; (7) provides technical supervision for division, state and 
local assignees; and (8) collaborates with other components of the 
division, NCHHSTP and CDC to develop and implement strategies and 
activities to meet goals for key division priorities.
    Office of the Director (CVJD1). (1) Plans, directs and evaluates 
the activities of the division; (2) provides national leadership and 
guidance in STD science, surveillance, prevention and control policy 
formulation; program planning, development, management, and evaluation; 
development of training, educational, and health communications; (3) 
provides operational, administrative, fiscal, technical, and logistical 
support for division programs and units; (4) assures multidisciplinary 
collaboration in STD prevention and control activities; (5) in 
cooperation with other CDC components, provides leadership for 
developing research relevant to STD prevention and control; (6) 
provides leadership, guidance, and coordinates development of 
guidelines and standards to assure ongoing high-quality performance of 
STD prevention and control programs; (7) coordinates global STD 
activity of the division; (8) collaborates, as appropriate, with other 
divisions and offices in NCHHSTP, and with other divisions throughout 
CDC; (9) collaborates as appropriate with external organizations 
outside of CDC to achieve the mission of the division; and (10) manages 
the Tuskegee Participants Health Benefits Program.
    STD Laboratory Reference and Research Branch (CVJDE). (1) Performs 
research on the pathogenesis, genetics, and immunology of syphilis, 
gonococcal and chlamydial infections, and other sexually transmitted 
infections (STI), including rare (e.g., chancroid) or emerging (e.g., 
Mycoplasma genitalium) STI; (2) conducts research and reference 
services to develop, evaluate, and improve laboratory STI diagnostics 
and methods; (3) participates in the design, implementation, and 
analysis of national and international STD epidemiology studies, 
surveillance activities, and biomedical interventions; (4) conducts 
laboratory-based surveillance for and research on the genetics of 
antimicrobial resistance in Neisseria gonorrhoeae and for other STIs; 
(5) serves as the WHO International Collaborating Center for Reference 
and Research in STI and as reference laboratory for WHO STD diagnostics 
and surveillance initiatives; and (6) develops STD laboratory 
guidelines.
    Program Development and Evaluation Branch (CVJDG). (1) Provides and 
facilitates technical assistance and capacity building to state and 
local health departments, non-governmental, and other partners in the 
planning, implementation, and evaluation of STD prevention and control 
strategies; (2) monitors and evaluates STD prevention strategies to 
assure programmatic objectives are being met and to track individual 
and collective progress over time; (3) conducts analysis of STD 
prevention and control strategies and collaborates with partners to 
resolve challenges and increase awareness of best practices; (4) 
develops and manages programs, solicitations, and evaluation projects 
to advance innovations and quality improvements in STD prevention and 
control strategies and activities; and (5) supports the identification, 
translation, dissemination, and adoption of evidence-based 
interventions and practices by state and local health departments, non-
governmental, and other prevention partners.
    Surveillance and Data Science Branch (CVJDH). (1) Assesses and 
disseminates data on STD burden, risks, and trends in STD morbidity and 
mortality; (2) leads, evaluates, and provides recommendations for 
improving STD surveillance systems; (3) provides leadership in the 
management and coordination of information systems that can 
electronically receive, store, and transmit STD surveillance and case 
management data; (4) provides surveillance, data management and public 
health informatics technical assistance and support to the division, 
local and state health departments, and other national and 
international partners; and (5) translates informatics best practices 
for STD electronic case reporting, clinical decision support, and other 
division efforts.
    Disease Intervention and Response Branch (CVJDJ). (1) Investigates 
STDs in the community (e.g., field testing, public health detailing, 
outbreak response, and contact tracing); (2) provides technical 
assistance and capacity in disease investigation to support communities 
and public health partners; (3) conducts activities to assure a 
competent disease investigation workforce (e.g., DIS certification, 
mentoring and training); and (4) provides linkage to services for STD 
prevention and control and other co-occurring activities (e.g., 
intimate partner violence, behavioral health, HIV care, PrEP, and 
reproductive health services).
    Behavioral Science and Epidemiology Branch (CVJDK). (1) Synthesizes 
evidence and critically appraises existing prevention science research, 
as related to STD priorities; (2) identifies and describes the context 
for effective STD prevention science; (3) provides national and 
international leadership in the design and dissemination of studies to 
implement STD prevention interventions at individual, group, community, 
and structural levels; and (4) translates or adapts research strategies 
and evaluation results from formative assessments and prevention 
interventions for programmatic action and to inform national STD 
prevention policy and program direction.
    Clinical, Economics, and Health Services Research Branch (CVJDL). 
(1) Develops and evaluates methodologies for conducting clinical, 
economic, modelling, and health services research related to STD 
prevention and control; (2) develops preventive clinical, health 
services, transmission dynamics, and cost-effectiveness models for STD-
related issues; (3) estimates the economic and health impact burden of 
STDs and cost-effectiveness of STD prevention; (4) develops, 
disseminates, and evaluates STD prevention and clinical guidelines; (5) 
provides technical assistance, training, and capacity building 
pertaining to clinical and health services-related aspects of STD 
prevention; and (6) provides statistical research and technical

[[Page 73056]]

assistance to others in the division and to local and state STD control 
programs.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-25194 Filed 11-13-20; 8:45 am]
BILLING CODE 4160-18-P